David Roblin

MedCity Ltd. is a central organization dedicated to accelerating innovation, investment, and growth within the life sciences sector. The private company is based in Canterbury, UK. It supports a broad range of life sciences companies—including biotech, medtech, diagnostics, digital health, and advanced therapies—by providing expert guidance, tailored business growth services, and access to a network of investors, academia, industry, and the NHS. MedCity runs programs such as Grow, Health Accelerator for Social Enterprise, TechBio Boost, Collaborate to Innovate, and the Investment Hub, which offer accelerators, seed funding, pitch events, mentorship, and strategic partnerships to help SMEs scale, secure investment, and expand internationally. The organization facilitates connections between SMEs and a network of over 400 angel and venture capital investors, and offers a free brokerage service to help companies find R&D and manufacturing lab space across key life science clusters. MedCity provides resources including setup guides for companies relocating or investing, market intelligence reports, sector analyses, and updates on funding and regulatory developments. Through events and newsletters, MedCity keeps stakeholders informed and engaged, emphasizing collaboration across the ecosystem to foster innovation and raise awareness of the region as a life sciences hub.

Functions as an investment holding company

Operates as an independent charity that engages in biomedicine research

Operates as an immunotherapy biotechnology company that engages in discovery and development of novel molecules targeting life threatening diseases

Operates as an end-to-end biotech developing transformational medicines

Engages in the discovery, development and commercialization of novel medicines

Operates as an independent charity that engages in biomedicine research